Akanda Total Liabilities and Share Holders Equity 2021-2024 | AKAN

Akanda total liabilities and share holders equity from 2021 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Akanda Total Liabilities and Share Holders Equity 2021-2024 | AKAN

Akanda total liabilities and share holders equity from 2021 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$203.4B
Stryker (SYK)$148.7B
Boston Scientific (BSX)$134.9B
EssilorLuxottica (ESLOY)$111.5B
Medtronic (MDT)$108.7B
Haleon (HLN)$43.2B
Lonza Group Ag (LZAGY)$42.4B
GE HealthCare Technologies (GEHC)$37.5B
ResMed (RMD)$35.8B
Terumo (TRUMY)$29.4B
Koninklijke Philips (PHG)$24.8B
Zimmer Biomet Holdings (ZBH)$21.6B
Insulet (PODD)$18.4B
Baxter (BAX)$16.8B
Smith & Nephew SNATS (SNN)$10.9B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.1B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.1B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.3B
Prestige Consumer Healthcare (PBH)$4.2B
ICU Medical (ICUI)$4.1B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.7B
Agios Pharmaceuticals (AGIO)$3.2B
Neogen (NEOG)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.8B
QuidelOrtho (QDEL)$2.5B